Supply of medicines – Lorlatinib active substance – ATC L01ED05

Summary

The tender concerns the ongoing supply of medicines containing the lorlatinib active substance (ATC L01ED05). The contract covers two dosage forms: lorlatinib 100 mg tablets (600 units, packed as 30x100 mg) and lorlatinib 25 mg tablets (300 units, packed as 90x25 mg). The estimated total contract value is 60,625,800 CZK. The delivery location is the pharmacy of Fakultní Thomayerovy nemocnice. The tender submission deadline is 23 October 2026 at 09:30. The procedure is open.